Biohaven Pharmaceutical Holding Co Ltd.

DEUTSCHE BANK AG\

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

53,372

Value ($000)

8,068

Weight

0.0%

2018 Q2 - 2022 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	8,068	0.0%	53,372	9/30/2022
2022 Q2	8/11/2022	14,416	0.0%	98,932	6/30/2022
2022 Q1	5/13/2022	91,401	0.0%	770,867	3/31/2022
2021 Q4	2/16/2022	109,969	0.0%	797,980	12/31/2021
2021 Q3	11/4/2021	102,512	0.0%	737,971	9/30/2021
2021 Q2	8/11/2021	73,227	0.0%	754,294	6/30/2021
2021 Q1	5/13/2021	49,668	0.0%	726,680	3/31/2021
2020 Q4	2/16/2021	10,041	0.0%	117,153	12/31/2020
2020 Q3	11/12/2020	34,305	0.0%	527,690	9/30/2020
2020 Q2	8/13/2020	44,645	0.0%	610,647	6/30/2020
2020 Q1	5/14/2020	19,273	0.0%	566,333	3/31/2020
2019 Q4	2/14/2020	26,823	0.0%	492,757	12/31/2019
2018 Q3	12/21/2021	9,951	—	265,010	9/30/2018
2018 Q2	4/21/2020	7,915	—	200,285	6/30/2018